Surgical Innovations Group plc (AIM:SUN)
London · Delayed Price · Currency is GBP · Price in GBX 0.5050
+0.0050 (1.00%)
Jul 31, 2026, 3:58 PM GMT
AIM:SUN Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5 | 4 | 5 | 6 | 15 | 22 | |
Market Cap Growth | -28.57% | -18.18% | -8.33% | -62.50% | -31.91% | 42.42% |
Enterprise Value | 5 | 6 | 6 | 6 | 14 | 20 |
Last Close Price | 0.01 | 0.00 | 0.01 | 0.01 | 0.02 | 0.02 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 56.53 | - |
Forward PE | - | 0.22 | 90.00 | 90.00 | 14.00 | 14.00 |
PS Ratio | 0.40 | 0.36 | 0.43 | 0.47 | 1.32 | 2.40 |
PB Ratio | 0.61 | 0.55 | 0.60 | 0.53 | 1.36 | 2.06 |
P/TBV Ratio | 2.10 | 1.89 | 1.65 | 1.42 | 2.69 | 4.18 |
P/FCF Ratio | 9.18 | 8.26 | - | 48.25 | - | - |
P/OCF Ratio | 8.20 | 7.38 | - | 13.99 | 30.71 | - |
PEG Ratio | - | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.47 | 0.48 | 0.53 | 0.51 | 1.26 | 2.22 |
EV/EBITDA Ratio | - | - | - | - | 59.45 | - |
EV/EBIT Ratio | - | - | - | - | 195.44 | - |
EV/FCF Ratio | 10.74 | 11.02 | - | 52.93 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.21 | 0.21 | 0.15 | 0.16 | 0.20 | 0.26 |
Debt / EBITDA Ratio | - | - | - | - | 5.05 | 64.81 |
Debt / FCF Ratio | 3.16 | 3.16 | - | 14.33 | - | - |
Net Debt / Equity Ratio | 0.10 | 0.10 | 0.13 | 0.04 | 0.00 | -0.08 |
Net Debt / EBITDA Ratio | -1.57 | -1.57 | -2.89 | -1.31 | -0.16 | 5.95 |
Net Debt / FCF Ratio | 1.56 | 1.56 | -7.66 | 3.88 | 0.22 | 1.33 |
Asset Turnover | 0.97 | 0.97 | 0.90 | 0.80 | 0.72 | 0.57 |
Inventory Turnover | 3.31 | 3.31 | 2.92 | 2.85 | 2.42 | 2.34 |
Quick Ratio | 0.75 | 0.75 | 0.73 | 1.07 | 1.36 | 1.22 |
Current Ratio | 1.48 | 1.48 | 1.88 | 2.32 | 2.54 | 2.01 |
Return on Equity (ROE) | -11.06% | -11.06% | -20.43% | -4.75% | 2.44% | -4.19% |
Return on Assets (ROA) | -3.81% | -3.81% | -3.00% | -2.46% | 0.29% | -1.57% |
Return on Capital Employed (ROCE) | -8.90% | -8.90% | -6.80% | -5.00% | 0.60% | -3.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -19.19% | -21.32% | -37.87% | -9.09% | 1.77% | -2.08% |
FCF Yield | 10.89% | 12.10% | -2.75% | 2.07% | -1.16% | -2.94% |
Buyback Yield / Dilution | - | - | - | 0.33% | 0.30% | -12.18% |